Company / Cash & Equivalents
DBV Technologies S.A. Cash & Equivalents History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$194.2M
FY2025
5-year range
$32.5M / $209.2M
FY2021-FY2025
Trend
+498.2%
vs FY2024
Sector context
#92 of 209
Health Care
What the data says
Cash & Equivalents changed +498% YoY in FY2025, a notable deviation from the 6-year average annual change of +83%.
Based on SEC 10-K filings.
$194M in FY2025 with a 5-year CAGR of -0.2%.
Improved from $141M to $194M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
#92 of 209 in Health CareTop 44% of 209This company $194.2M Sector average $696.0M
▼
-72.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -0.2%, indicating a declining trend.
- In FY2025, cash & equivalents increased 498.2% year-over-year.
- Ranks #92 out of 209 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $194.2M | +498.2% |
| FY2024 | $32.5M | -77.0% |
| FY2023 | $141.4M | -32.4% |
| FY2022 | $209.2M | +170.6% |
| FY2021 | $77.3M | -60.6% |
| FY2020 | $196.4M | +1.6% |
| FY2019 | $193.3M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026